This article is more than 5 years old. Information may no longer be current.

Alcon net sales increased to $10.8 billion in 2014

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Alcon’s net sales for fiscal year 2014 totaled $10.8 billion, a 3% increase from the previous year, according to a press release from Novartis.

Surgical, ophthalmic pharmaceuticals and vision care sales grew by 5%, 3% and 2%, respectively, for the full year.

Operating income increased 30% to $1.6 billion in the fiscal year. In the fourth quarter 2014, operating income increased 112% to $365 million from the fourth quarter 2013.

Alcon’s net sales for the fourth quarter totaled $2.7 billion, a 2% increase from the fourth quarter 2013.

Novartis net sales increased by 1% to $58 billion in 2014. Fourth quarter net sales totaled $14.6 billion. Operating income grew 1% to $10.7 billion, with $1.2 billion in operating income in the fourth quarter. Net income increased by 12% to $10.3 billion in the fiscal year, with $1.5 billion in net income in the fourth quarter.